Comprehensive Assessment of Reactogenicity and Safety of the Live-Attenuated Chikungunya Vaccine (IXCHIQ<sup>®</sup>)

<b>Background/Objectives:</b> This overview provides a comprehensive safety evaluation of the approved live-attenuated vaccine VLA1553 (IXCHIQ<sup>®</sup>) for active immunization for the prevention of disease caused by chikungunya virus (CHIKV) in clinical trials. <b>M...

Full description

Saved in:
Bibliographic Details
Main Authors: Gabriele Maurer, Vera Buerger, Julian Larcher-Senn, Florian Erlsbacher, Stéphanie Meyer, Susanne Eder-Lingelbach, Juan Carlos Jaramillo
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/6/576
Tags: Add Tag
No Tags, Be the first to tag this record!